-
The Economic Case for Wiping Out Ebola
On Aug. 22, the World Health Organization announced a draft strategy to combat the West African Ebola outbreak over the next six to nine months. That’s a sign that the global health body isn’t optimistic about a rapid end to an epidemic that has killed around 1,300 people so far. An extended outbreak of such a feared disease would have mounting economic costs.
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
-
Glimmer of hope seen in Ebola outbreak
Three health care workers who were given the experimental Ebola drug ZMapp in Liberia have shown "very positive signs of recovery," the Liberian Ministry of Health said Tuesday. Medical professionals treating the workers have called their progress "remarkable."
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Humans give malaria to mosquitoes – we need a vaccine to stop this
On Wednesday, the world marks World Mosquito Day to commemorate the 1897 discovery by British doctor Sir Ronald Ross that malaria in people is transmitted to and from mosquitoes. Ross won a Nobel prize for his discovery, and, since then, mosquitoes have been enemy No 1 when it comes to defeating a disease that takes a life every single minute – most of them children in sub-Saharan Africa. But on this day, let’s focus on approaching malaria in a surprising new way: a vaccine to stop humans from giving malaria to mosquitoes.
- Categories
- Education, Health Care
- Tags
- product design, research, vaccines
-
Dengue vaccine is just a year away, researchers say
A new vaccine that can halve the number of dengue cases provides a welcome shot to fight a deadly disease that infects around 390 million people every year in the tropics.
- Categories
- Education, Health Care
-
‘No Market’: Scientists Struggle to Make Ebola Vaccines, Treatments
At least four vaccines are being developed to protect people against Ebola, including one that protects monkeys completely against the deadly virus. Several groups are also working on treatments, but one of the most promising is stuck in safety testing.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
GSK seeks approval for world’s first malaria vaccine
LONDON (Reuters) - GlaxoSmithKline said on Thursday it is applying for regulatory approval for the world's first vaccine against malaria, designed for children in Africa.
- Categories
- Health Care
-
How to Be an International Dealmaker: Market nudges are building global vaccine markets
Vaccines are effective and relatively inexpensive health interventions but, for a variety of reasons, many potential vaccines are never developed, distributed or tailored to work effectively in the Global South. Recent risk reduction measures, however, show promise toward reducing vaccine prices and increasing access while engaging manufacturers and stimulating innovation in the market.
- Categories
- Health Care
- Tags
- vaccines
-
Reuters: Sanofi plans to put dengue program into separate unit
Sanofi ($SNY) has been working on a vaccine to protect against the mosquito-borne dengue virus for 20 years, and now it may be breaking that program off into a distinct unit.
- Categories
- Health Care
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.